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Conjugated linoleic acids (CLA) have been shown to decrease body fat content in pigs. It is possible that feeding pigs diets rich in CLA
may increase carcass lipid CLA to levels that could provide health benefits when included as a part of a healthy diet. Therefore, the aim of
the present study was to determine whether dietary CLA supplementation has any effect on the fatty acid composition of subcutaneous and
intramuscular adipose tissue in pigs. Thirty-five female cross bred (Large White £ Landrace) pigs (initial weight 57·2 kg and initial P2
back fat 11·5 mm) were used in the present study. Pigs were housed individually and randomly allocated to one of six dietary treatments
(0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g CLA55 (55 g CLA isomers/100 g total fatty acids; Natural Lipids Ltd, Hovdebygda, Norway)/kg)
and fed their respective diets for 8 weeks. Twelve CLA isomers in the diet and in pig tissue lipids were separated by Agþ-HPLC. CLA was
incorporated at fivefold higher levels in subcutaneous fat as compared with intramuscular fat and in a dose-dependant manner. Overall, the
transfer efficiency of CLA was maximized at 5·00 g CLA55/kg. However, there was clear selectivity in the uptake or incorporation of
cis,trans-9,11 isomer over the trans,cis-10,12 isomer. In general, CLA supplementation produced significant changes in skeletal muscle
and adipose tissue fatty acid composition, indicating that dietary CLA had a potent affect on lipid transport and metabolism in vivo. Sig-
nificant increases in myristic, palmitic and palmitoleic acids and a reduction in arachidonic acid were observed, suggesting an alteration in
activity of D5-, D6- and D9-desaturases in pig adipose tissue. In conclusion, feeding pigs diets supplemented with CLA increases carcass
lipid CLA, but also results in changes in the fatty acid profile in pig fat that could potentially outweigh the benefits of CLA.
Conjugated linoleic acid: Fatty acids: Pigs
With the increasing awareness of the importance of
healthy diet in cancer prevention, there is interest in the
manipulation of animal products to meet consumer
demands for functional foods (Jime´nez-Colmenero,
2001). There is convincing evidence from rodent models
and in vitro models of carcinogenesis indicating that con-
jugated linoleic acid (CLA) is a potent naturally occurring
anti-carcinogen (Shultz et al. 1992; Ip et al. 1994; Parodi,
1994; Durgam & Fernandes, 1997). Human clinical and
epidemiological results are more equivocal, with one
study showing an inverse association between dietary
and serum CLA and risk of breast cancer, particularly in
postmenopausal women (Aro et al. 2000), although this
was not confirmed in another study (Voorrips et al.
2002). CLA is a mixture of positional and geometric iso-
mers (18 : 2n-6) of linoleic acid (cis-9,cis-12-octadecadie-
noic acid) with conjugated double bonds at positions
9,11-, 10,12- or 11,13- on the C-chain of linoleic acid.
The most common form in human diets is cis-9, trans-
11 CLA and the major source is the consumption of fat
in dairy products (Ritzenthaler et al. 2001). Based on
animal results, it was estimated that consumption of a
diet containing as little as 1 g CLA/kg dry diet is sufficient
to significantly reduce the incidence of tumours (Ip et al.
1994). Unfortunately, with the increasing consumption of
low-fat dairy products and consequently a reduced intake
of dairy fat, the richest source of CLA, these levels are
often not met. Therefore, development of CLA-fortified
products may help to increase the intake of CLA in the
human diet; clearly more clinical studies are required
before recommendations on the optimum amount of
CLA in the human diet can be made.
Meanwhile, the potential to increase the level of CLA in
animal fats via CLA supplementation of animal diets is
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being explored. Consumption of CLA-enriched animal
products by human subjects could help to increase the
CLA intake, since animal fat constitutes about 60 % of
the fat available for consumption in developed countries
such as Australia (Anonymous, 2000). Dietary CLA has
been shown to be readily incorporated into liver and
muscle lipids of the laboratory animals (Chin et al. 1994;
Park et al. 1995; Banni et al. 1996; Belury & Kempa-
Steczko, 1997), but the incorporation of CLA varied
according to the amount present in the diet and the
length of time of intake (Banni et al. 1996; Ip et al.
1996; Belury & Kempa-Steczko, 1997). CLA supplemen-
tation has also been reported as modifying fatty acid com-
position in pig tissue (O’Quinn et al. 2000; Eggert et al.
2001; Ramsay et al. 2001; Joo et al. 2002). The current
study is an extension of our previous report (Ostrowska
et al. 2003), where the supplementation of commercially
sourced CLA (consisting of a mixture of at least twelve
CLA isomers) was shown to improve performance and
carcass composition. The objective of the present study
was to investigate the effect of CLA supplementation on
the fatty acid composition of adipose tissue and intramus-
cular fat of pork.
Experimental methods
Animals and sample collection
All procedures involving animals were approved by the
Victorian Institute of Animal Science Animal Ethics Com-
mittee (Anonymous, 1997). Thirty-five (Large White £
Landrace) pigs were used in the experiment. Five pigs
were killed at the beginning of the experiment. The
remaining thirty pigs were blocked according to the live
weight (57·2 (SD 1·9) kg) and back-fat thickness (11·5
(SD 1·3) mm) and randomly allocated to one of six dietary
treatments. The CLA used in the present study was pre-
pared from sunflower oil and contained 55 g CLA isomers
in non-esterified fatty acid form/100 g total fatty acids
(CLA55; Natural Lipids Ltd, Hovdebygda, Norway). The
CLA concentrations for the six diets were 0·00, 1·25,
2·50, 5·00, 7·50 or 10·00 g CLA55/kg diet or 0·00, 0·70,
1·40, 2·75, 4·10 and 5·50 g total CLA/kg diet. The CLA
content of the supplement and diets was measured by
HPLC as described later (Cross et al. 2000; Ostrowska
et al. 2000).
The experimental diets were formulated to contain
14·3 MJ digestible energy, 9·3 g lysine and 175 g crude
protein (N £ 6·25)/kg air-dry diet, which was in excess
of protein and lysine requirements for the class of pig
used in the study (Dunshea et al. 1993). The detailed
diet composition has been published elsewhere (Ostrowska
et al. 2003). The amino acid content relative to lysine
was kept in excess of the amino acid balance proposed
as ideal by the Standing Committee on Agriculture
(1987) to ensure that lysine was the first limiting amino
acid. Diets were fed ad libitum for 8 weeks and unlimited
access to water was provided via nipple drinkers. Pigs
were housed individually to allow measurement of indi-
vidual feed intake daily and live weight measurements
weekly.
After 8 weeks, pigs were slaughtered at an average live
weight of approximately 107 kg (Ostrowska et al. 2003).
Two samples of adipose tissue were collected from the
P2 site (65 mm from the midline over the last rib): the
inner layer (adjacent to longisimus thoracis muscle) of
fat and the outer layer of fat (5 mm beneath the skin)
were collected immediately after slaughter. Samples
of muscle tissue were also collected from longissimus
thoracis at the P2 site. The samples were stored at
2808C before being analysed for the fatty acid compo-
sition and CLA isomer profile.
Sample preparation for fatty acid analysis
Fat was extracted using a chloroform–methanol (2:1, v/v)
method (Folch et al. 1957). Preparation of non-esterified
CLA was carried out according to the procedure of Ha
et al. (1989). For GC analysis, non-esterified fatty acids
were derivatized into methyl esters using the BF3 method
(Association of Official Analytical Chemists, 1995).
CLA were separated by HPLC using a ChromSpher 5
Lipids analytical (4·6 mm internal diameter £ 250 mm,
stainless steel, 5mm particle size) Ag-impregnated
column (Chrompack, Bridgewater, NJ, USA). The
column was protected by a 3·0 mm internal diameter £ 10
mm guard column containing the same stationary phase.
HPLC analyses were performed with a Varian (Walnut
Creek, CA, USA) isocratic solvent delivery system
equipped with a 9012 pump, a Prostar 330 photodiode
array detector (ProStar, Varian Inc, Palo Alto, CA, USA)
and a Star Workstation (version 5.3 Star software; Varian
Inc.). All absorbances were measured at 234 nm. Samples
were introduced via a Rheodyne (Cotati, CA, USA) 8125
injector fitted with a 5ml injection loop. A Timberline
(Eureka, OR, USA) column heater maintained the tempera-
ture at 308C for all runs. Minimum tubing diameters and
distances were used between the injector and detector.
The conditions used for separation of CLA non-esterified
fatty acids in pig tissue were glacial acetic acid (25 ml/l)
and acetonitrile (0·25 ml/l) at a flow rate of 1 ml/min.
GC analysis of fatty acid methyl esters was carried out
with a 3400 Varian GC (Varian Inc.) fitted with a flame
ionization detector. A HP-INNO Wax (Hewlett Packard,
Palo Alto, CA, USA), polyethylene glycol fused silica
capillary column (60 m £ 0·32 mm (internal diameter),
0·25mm film thickness) was used with he as the carrier
gas at a flow rate of 2 ml/min (81·36 kPa).
Lipid standard (Sigma-Aldrich Pty Ltd, Castle Hill,
NSW, Australia) containing thirty-seven different fatty
acid methyl esters was used to determine the best con-
ditions for separating all fatty acids present. The lipid
standard was then spiked with the 99 % pure CLA stan-
dard (Sigma-Aldrich Pty Ltd) containing twelve isomers,
to ensure there was minimal overlapping of the peaks
with the remaining fatty acid methyl esters. The con-
ditions chosen were as follows: injector temperature set
at 2508C, detector temperature at 2508C and oven tem-
perature programmed into four progressive steps: step 1,
508C held for 1 min; step 2, 50–1008C at 208C/min and
held for 1 min; step 3, 100–1808C at 208C/min and held
for 2 min; step 3, 180–1958C at 18C/min and held for
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1 min; step 4, 195–2308C at 108C/min and held for
30 min. The volume injected ranged from 1·0 to 3·0ml.
The CLA fatty acids and other fatty acid methyl ester
peaks were identified by comparison with the retention
time of the reference standard.
Calculations and statistical analysis
Transfer efficiencies of the CLA isomers into porcine
tissue were calculated using the following formula:
transfer efficiency ð%Þ
¼ ððfin: CLA2 init: CLAÞ
2 T0 fin: CLA2 T0 init: CLAÞ
£ =total CLA mass consumedÞ £ 100;
where fin. CLA is the final CLA mass (g), init. CLA is the
initial CLA mass (g), T0 fin. CLA is the final CLA mass (g)
in the control group of pigs and T0 init. CLA is the initial
CLA mass (g) in the control group of pigs.
One assumption in the estimations of transfer efficien-
cies was that the initial intramuscular fat content was a uni-
form value of 1·5 % body weight. This was based on the
analysis performed on the five pigs that were killed at
the beginning of the experiment. The estimations of the
initial fat and lean contents for the individual pigs were
obtained by the dual–energy X–ray absorptiometry. The
total intramuscular fat mass at the beginning of the exper-
iment was calculated by multiplying the initial intramuscu-
lar % fat by dual–energy X–ray absorptiometry estimation
of the total lean content for every pig (Ostrowska et al.
2003). The initial subcutaneous fat content was assumed
to be the difference between the estimation of initial fat
content by dual–energy X–ray absorptiometry and the
estimation of the initial intramuscular fat content. The sub-
cutaneous CLA content at the beginning of the experiment
was assumed to be a sum of CLA found in the inner and
the outer layers of fat, and equal to the amount found in
the control group of pigs at the end of the experiment, mul-
tiplied by the initial content of total subcutaneous fat. Simi-
larly, the initial intramuscular CLA contents were assumed
to be equal to the amount found in the control group at the
end of the experiment.
Statistical analysis
Data were analysed by ANOVA suitable for a dose–
response, with linear and quadratic effects determined.
The model included replicate and CLA dose. In addition,
comparisons were made between diets containing either
none or added CLA. For these analyses, the model
included block, replicate and CLA dose. All analyses
were performed using GENSTAT for Windows, version
4.1 (Payne et al. 1993).
Results
Appropriate blocking ensured that there was no difference
in live weight (57·2 kg, P¼0·76) or P2 (11·5 mm, P¼0·20)
back fat between the different dietary CLA groups at the
commencement of the study. Effects of dietary CLA on
growth performance have been presented elsewhere, but
briefly, there was no effect of CLA on average daily
gain, while there was a small improvement in the ratio
feed:gain with dietary CLA supplementation (Ostrowska
et al. 2003). Significantly linear dose–dependent
reductions in fat mass were observed in the carcass at the
end of the study (Ostrowska et al. 2003).
The isomer composition of the dietary CLA, which was
analysed by Agþ-HPLC, is shown in Table 1. Once CLA
was mixed in the diet, both GC and Agþ-HPLC analyses
were used to confirm the content of CLA. Table 2 shows
the GC analysis of the fatty acid composition of the fats
extracted from the diets. The chromatographic analysis
of the fats extracted from the diets confirmed that the diet-
ary CLA was present at the expected levels (0·00, 0·69,
1·38, 2·75, 4·13 and 5·50 g CLA/kg diet). However, the
substitution of CLA with soyabean oil resulted in small
differences in the fatty acid profile of the fats extracted
from the diets (Table 2). For example, soyabean oil con-
sisted of about 500 g linoleic acid (18 : 2)/kg with 450 g
commercial mixture of CLA55/kg. Hence, control diets
were slightly higher in linoleic acid content as compared
with diets supplemented with CLA. This was also the
case for myristic (14 : 0), palmitic (16 : 0), stearic (18 : 0)
and linolenic acids (18 : 3), whereas the concentration of
g-linoleic (g-18 : 3) acid increased with the dietary CLA
in the diet.
Agþ-HPLC analysis of the CLA isomer composition in
the outer layer and inner layers of fat and intramuscular
fat are presented in Tables 3, 4 and 5 respectively. Small
amounts of CLA were detected in pigs fed the control
diets, with the highest quantity present in the inner layer
of fat (1·73 mg/g fat), followed by the outer layer
(0·68 mg/g fat), and lowest in the intramuscular fat
(0·43 mg/g fat). The concentration of CLA detected varied
across different fat depots; however, in all cases the levels
increased in a linear fashion with the increasing level of
dietary CLA in the diet. The significant (P,0·001) linear
Table 1. Distribution of non-esterified conjugated linoleic acid
(CLA) isomers in the CLA fraction of the commercial preparation of
CLA55*
CLA isomer g/100 g total CLA isomers
cis,trans/trans,cis-11,13† 18·33
cis,trans/trans,cis-10,12† 30·45
cis,trans/trans,cis-9,11† 24·53
cis,trans/trans,cis-8,10† 13·83
trans,trans-11,13 0·18
trans,trans-10,12 0·44
trans,trans-9,11 2·04
trans,trans-8,10 2·90
cis,cis-11,13 0·82
cis,cis-10,12 2·64
cis,cis-9,11 3·18
cis,cis-8,10 ND
Total 99·35
ND, not detected.
* CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55;
Natural Lipids Ltd, Hovdebygda, Norway).
† The slash between geometric isomers (i.e. cis,trans/trans,cis) means that
either or both of the two isomers could be present.
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increase in the concentration was evident for all the individual
isomers of CLA detected in pig tissues. In the inner layer
of fat and at the highest level of CLA supplementation as
much as 15·10 mg total CLA was detected per g total
lipids (Table 4). Slightly less CLA was detected in the
outer layer of fat (13·50 mg/g fat; Table 3) and fivefold
lower concentrations were detected in the intramuscular
fat (2·88 mg/g fat; Table 5). In terms of individual isomers
of CLA, the cis,trans-9,11 isomer was most abundant in all
three fat depots. At the highest level of dietary CLA sup-
plementation, the levels were 5·51, 5·63 and 0·70 mg/g
fat collected from outer layer, inner layer and intramuscu-
lar fats respectively (Tables 3, 4 and 5). In the trans,trans
and cis,cis group of isomers, the 9,11 isomer was also most
abundant in all three fat depots, followed by a 10,12 homo-
log (Tables 3, 4 and 5).
Approximately one-third (29·28 %) of the total dietary
CLA consumed by the pigs was incorporated into carcass
lipid (sum of intramuscular, the inner and the outer
layers of fat; Table 6). The highest transfer efficiency
value (39·17 %) was recorded for the group of pigs fed
the intermediate level of dietary CLA (5·00 g/kg). The
transfer efficiency of CLA into the intramuscular fat was
maximized (0·76 %) at 7·50 g CLA/kg diet (Table 6). The
distribution of CLA isomers isolated from the intramuscu-
lar fat appears similar to that found in the diet; however,
the incorporation of some isomers was less than that of
others (Table 6). The most evident difference was in the
incorporation of the trans,cis-10,12 isomer, which was
the most abundant isomer in the CLA mixture fed to the
pigs, but the least efficiently incorporated isomer in the
porcine tissue. For the individual isomers in the cis,trans
region, the transfer efficiencies in the intramuscular fat
were maximized at the dietary CLA level of 7·50 g/kg
(1·18, 0·36, 0·94 and 1·03 % for cis,trans-11,13, -10,12,
-9,11 and -8,10 isomers respectively).
The transfer efficiency of the dietary CLA was much
greater (P,0·001) in the subcutaneous fat, at 28·78 %
across all dietary levels of CLA compared with 0·50 % in
the intramuscular fat (Table 6). The incorporation of total
CLA into adipose tissue was maximized at dietary CLA
concentration of 5·00 g/kg (38·42 %) followed by 7·50 g
CLA/kg (37·58 %). The incorporation efficiencies esti-
mated for the individual isomers (Table 6) show that the
trans,cis 2 10,12 isomer was the least abundant isomer
found in the subcutaneous fat. Overall, 13·30 % of this
isomer was incorporated into subcutaneous fat. The
cis,trans 2 9,11 was the most efficiently incorporated
isomer, with almost half (46·40 %) of the amount of this
isomer fed to the pig being incorporated into the adipose
tissue. The second most efficiently incorporated isomer
was the trans,cis 2 8,10 (28·78 %), followed by the
cis,trans 2 11,13 isomer (20·81 %). The transfer efficiency
of the cis,trans 2 9,11 isomer was maximized at the diet-
ary CLA level of 5·00 g/kg (66·4 %). The cis,trans 2 8,10
homolog was incorporated most efficiently at concentration
of 7·50 g dietary CLA/kg diet (39·23 %). The transfer effi-
ciencies for the remaining two isomers in the cis,trans
group were maximized (29·72 and 18·16 % for
cis,trans 2 11,13 and 210,12 respectively) at the highest
level of supplementation.
The transfer efficiencies for total CLA and the individual
isomers tended to increase significantly (P,0·001) with
the increasing dietary level of CLA. The lowest value of
transfer efficiency was recorded at the dietary CLA con-
centration of 1·25 g/kg (7·40 %). This could be partially
due to the assumptions made in regards to the levels of
CLA found in the adipose tissue at the beginning of the
experiment. Because the CLA isomer composition of
pigs at the beginning of the experiment was not analysed,
the value adopted in the calculations of the transfer effi-
ciencies was the concentration found in the control group
of pigs at the end of the experiment. The concentrations
of CLA are anticipated to be higher in heavier pigs than
younger pigs, since CLA is known to originate from diet-
ary sources and its accumulation in tissue is time depen-
dent. Hence, the transfer efficiencies are possibly slightly
underestimated and the values calculated for the lowest
level of dietary CLA tended to be most sensitive to this
assumption; in some pigs, the transfer efficiency values
resulted in negative values.
The GC results of the fatty acid profiles in adipose
and muscle tissues are presented in Tables 7 and 8. The
distribution of fatty acids was clearly affected by dietary
Table 2. Fatty acid composition of the total lipids extracted from the diets fed to the pigs*
g/100 g total fatty acids
Fatty acid Diet 1† Diet 2† Diet 3† Diet 4† Diet 5† Diet 6†
14 : 0 0·58 0·56 0·54 0·53 0·51 0·50
16 : 0 11·87 11·25 10·87 10·68 10·19 9·71
18 : 0 12·50 12·40 11·97 11·13 10·29 9·45
18 : 1 22·58 21·94 21·22 22·57 22·57 22·58
18 : 2n-6 45·52 44·58 42·66 40·48 37·73 34·98
Sn-6 CLA ND 1·70 3·67 7·43 10·89 14·92
18 : 3n-3 4·95 4·79 4·62 4·30 3·97 3·65
g-18 : 3n-3 0·15 0·19 0·21 0·67 0·93 1·18
20 : 0 0·12 0·12 0·11 0·10 0·10 0·09
22 : 6n-3 0·27 0·26 0·25 0·23 0·23 0·20
ND, not detected.
* Fats were extracted using chloroform–methanol (2:1, v/v) method (Folch et al. 1957); total fat
extracted from the diets was 36 (SD 1·2) g/kg diet.
† Diets 1–6 correspond to different dietary levels of CLA included in the diet: (g CLA/kg diet): diet 1
(control) 0·00, diet 2 1·25, diet 3 2·50, diet 4 5·00, diet 5 7·50, diet 6 10·00.
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CLA. CLA reduced the levels of oleic (18 : 1), arachidic
(20 : 0), eicosatrienoic (20 : 3) and arachidonic (20 : 4)
acids in a linear fashion, while the content of decosahex-
aenoic acid (22 : 6) generally tended to be elevated at
intermediate levels of dietary CLA. The relative pro-
portions of the lauric (12 : 0), myristic (14 : 0), palmitic
(16 : 0) and palmitoleic (16 : 1) acids were increased
with the increasing concentration of CLA in the diet,
despite their reduced levels in the diets supplemented
with CLA (Table 2). The concentrations of linoleic acid
(18 : 2) were similar in the inner layer of fat for different
levels of dietary CLA supplementation, while they was
reduced in a quadratic fashion in the intramuscular fat.
The relative proportions of other fatty acids such as
capric acid (10 : 0), stearic acid (18 : 0) and g-linolenic
acid (18 : 3) were also not affected by dietary CLA
(Tables 7 and 8).
In the inner layer of fat (Table 7), CLA supplementation
at lower concentrations of dietary CLA of 1·25, 2·50 and
5·00 g/kg diet reduced the level of saturated fatty acids
(by 3·90, 6·80 and 2·20 g/100 g total fatty acids respectively)
and increased the level of unsaturated fatty acids (by 6·50,
9·30 and 2·30 g/100 g total fatty acids respectively). At diet-
ary CLA levels of 7·50 and 10·00 g/kg the levels of saturated
fatty acids were higher (by 1·00 and 2·20 g/100 g total fatty
acids) and unsaturated fatty acids were lower (by 1·70 and
3·80 g/100 g total fatty acids) than for the control pigs.
However, the difference between the CLA treatments
and control pigs were not significant for both the
saturated (P¼0·28) and unsaturated (P¼0·17) fatty acids.
The resulting ratio unsaturated : saturated fatty acids
increased from 0·50 to 0·53; however, the differences
were not significant (P¼0·18). There was a trend
(P¼0·06) towards linear reduction in proportion of
monounsaturated (total of 16:1 and 18:1) fatty acids in
pigs fed dietary CLA; however, the levels tended to be
higher for lower concentrations of dietary CLA (15·94,
16·78, 16·39, 14·22, 14·18 and 13·53 g/100 g total fatty
acids for 0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g/kg CLA
respectively).
The increase in the proportion of saturated fats was more
evident in the muscle tissue, where there was a significant
linear increase (P¼0·006; Table 8). The highest proportion
of saturated fatty acids was found in pigs fed 7·50 g CLA/kg
diet: 67·47 compared with 61·14 g/100 g total fatty acids in
the control group. In general, CLA-fed pigs had 5·00 g more
saturated fatty acids/100 g total fatty acids than control
pigs (P¼0·07). The proportion of unsaturated fatty acid
tended to decrease quadratically (P¼0·07), with the
lowest level (27·58 g/100 g total fatty acids) detected in
pigs fed 7·50 g/kg and the highest in the control group
(31·71 g/100 g total fatty acids). This resulted in a quadratic
response (P¼0·07), of the ratio unsaturated : saturated
fatty acids.
In general, CLA-fed pigs had 13·50 % lower ratio unsa-
turated : saturated fatty acids when compared with the con-
trol pigs (P¼0·06). The proportion of monounsaturated
(16 : 1 and 18 : 1) fatty acids remained unchanged (17·51,
18·04, 16·91, 16·42, 16·43 and 17·09 g/100 g total fatty
acids for 0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g/kg CLA
respectively; P¼0·44) in CLA-fed pigs.
Discussion
Incorporation of conjugated linoleic acid into tissues
The present results clearly indicate that supplemental diet-
ary CLA was primarily incorporated into adipose tissue
and to a lesser extent into intramuscular fat. Low
concentrations of CLA, predominantly the most abundant
naturally occurring isomer cis,trans-9,11 isomer (Parodi,
1994), were found in the corresponding tissues of control
pigs. The CLA found in tissue from the control pigs prob-
ably originated from endogenous desaturation of trans-11-
18 : 1 (Gla¨ser et al. 2002), since there was no CLA detected
in the control diet. However, Chin et al. (1994) also
reported that the large intestine of rodents had bacteria
that had the ability to biohydrogenate linoleic acid to pro-
duce cis,trans-9,11 CLA and it is possible that this may
occur in the relatively active hindgut of the pig.
The incorporation of individual and total isomers of
CLA into adipose tissue increased proportionally with
increasing level of dietary CLA, which is in agreement
with earlier studies in mice (Belury & Kempa-Steczko,
1997), rats (Chin et al. 1994; Sugano et al. 1997), hamsters
(de Deckere et al. 1999) and pigs (Kramer et al. 1998). The
difference between the total level of CLA found in the
inner and outer layers of subcutaneous fat was very small
but consistent across all levels of CLA supplementation,
indicating a similar incorporation of CLA isomers into
these two fat depots. However, fivefold lower levels of
CLA were found in the intramuscular fat (2·88 mg/g fat
at the highest level of CLA supplementation) in the
present study.
Although the concentration of individual isomers
increased with the level of dietary CLA, there was
obviously some selectivity in the uptake or incorporation
of certain isomers, especially the cis,trans isomers. The
calculated transfer efficiencies for the individual isomers
showed that the cis,trans-9,11 isomer was most efficiently
incorporated (46·40 %) in subcutaneous tissue, whereas in
the intramuscular fat, the cis,trans-11,13 isomer was
incorporated most efficiently (0·74 %). The preferential
enrichment of cis,trans-9,11 is of particular value with
respect to potential health benefits, as there is extensive
evidence showing anti-cancer properties of this CLA
isomer (for reviews, see Whigham et al. (2000) and
Pariza et al. (2001)). The cis,trans-10,12 isomer, which
is thought to be responsible for the reduction in lipid
accretion and storage in growing animals (de Deckere
et al. 1999; Park et al. 1999), was incorporated less effi-
ciently, in both subcutaneous and intramuscular fat (13·31
and 0·31 % respectively), than the remaining isomers in
the trans,cis group (Table 6). The isomer selectivity for
the transfer efficiencies found in the present study was
in agreement with studies in rodents (Park et al. 1999),
dairy cows (Chouinard et al. 1999a,b; Baumgard et al.
2001) and pigs (Kramer et al. 1998). In dairy cows,
trans,cis-10,12 is incorporated into milk fat with about
one-half the efficiency found for the cis,trans-9,11
isomer (Chouinard et al. 1999a,b). Kramer et al. (1998)
examined the incorporation of commercial CLA in many
of the tissue lipid classes of pigs and found that preferen-
tial incorporation of the cis,trans-9,11 isomer into liver
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phospholipids and of the cis,trans-11,13 isomer into heart
lipids. In both liver and heart lipids, the relative pro-
portions of trans,cis-10,12 and trans,cis-8,10 were signifi-
cantly lower than that found in the diet (Kramer et al.
1998).
These findings imply that the levels of CLA can be
increased in pig adipose tissue and intramuscular fat to
levels similar to those reported in literature for dairy pro-
ducts (typically 2–24 mg/g fat). Thus, there is a potential
to substantially increase the level of CLA, particularly
the cis,trans-9,11 isomer, which is more readily incorpor-
ated into animal fats, through supplementing CLA into
animal diets and consequently increase CLA intakes in
human diets.
Changes in fatty acid composition
Dietary polyunsaturated fats (both n-6 and n-3 fatty acid
families) are readily incorporated into porcine adipose
tissue lipids in a dose-dependent manner (Fontanillas
et al. 1997; Warnants et al. 1999) with a resultant decrease
in monounsaturated fatty acids, but little effect on satu-
rated fatty acid content (Bee et al. 1999). In the present
study, diets were formulated to contain CLA and/or soya-
bean oil. Substitution of soyabean oil with various
amounts of CLA resulted in dose-dependent changes in
myristic, palimitic, stearic and linolenic acid concen-
trations in the diets (Table 2). Hence, some differences
in the fatty acid profiles of the tissue lipids were antici-
pated due to differences in the fatty acid profile in the
diets. Therefore, care should be taken in interpreting
effects of CLA supplementation on changes in the profiles
of other fatty acids.
Despite this caveat, it does appear that some changes in
the fatty acid composition of porcine adipose tissue could
be attributed to dietary CLA. For example, the concen-
trations of palmitoleic (16:1) and palmitic (16:0) acids in
both intramuscular and subcutaneous fat increased in a
linear fashion with increasing dietary CLA. This was
clearly due to an effect of dietary CLA, since the level
of dietary palmitic acid decreased with increasing dietary
CLA. Palmitoleic acid was not detected in the diets; there-
fore, its origin was from desaturation of the respective
saturated fatty acid, palmitic acid, which is in turn regu-
lated by the fatty acyl-CoA D9-desaturase complex (Bee,
2000). The ratio palmitoleic : palmitic acid in the adipose
tissue of the CLA supplemented pigs in general was not
different from the control group, suggesting little effect
of CLA on desaturation activity. When considering the
fact that CLA supplementation results in dose-dependant
reductions in fat deposition (Ostrowska et al. 1999,
2003), it appears that the increase in the concentration of
these fatty acids is more likely to be due to the reduction
in the fat deposition in CLA-fed pigs, than altered desatur-
ase activity.
The D9-desaturase enzyme complex is also responsible
for desaturation of stearic acid into oleic acid. In a present
study, the concentration of stearic acid was not affected by
dietary CLA despite the levels decreasing as the CLA
increased in the diets, but a significant reduction in oleic
acid was detected despite similar levels found in all the
six diets. Similarly, Bee (2000) and Ramsay et al.
(2001) reported a distinct shift toward lower oleic acid
concentrations due to dietary CLA. This could be due to
the depressed synthesis of oleic acid in the adipose
tissue lipids, possibly due to decreasing stearoyl-CoA
desaturase activity. Lee et al. (1998) provided evidence
that CLA reduces the stearoyl coenzyme A desaturase
mRNA abundance in rat liver by 45 %. Similarly, in
dairy cows, dietary CLA influenced fatty acid composition
of meat and milk through inhibition of desaturases at the
level of transcription (Baumgard et al. 2002). In addition,
Baumgard et al. (2001) and Peterson et al. (2002) have
shown that the inhibition of desaturase is related to dose
of CLA and at lower doses (,7 g/d), where a 30 %
reduction in milk fat yield is evident, there is no effect
of desaturase activity.
A significant linear reduction in arachidonic acid, in both
the adipose tissue and intramuscular fat was detected in
CLA-fed pigs. The arachidonic acid was not of dietary
origin; therefore, it is likely that it was derived from desa-
turation of linoleic acid (18 : 2) or/and CLA to g-linolenic
acid (18 : 3) by D6-desaturase and elongation and sub-
sequent desaturation of dihomo-g-linolenic acid (20 : 3)
by a D5-desaturase (Stone et al. 1979). Therefore, it is
possible that CLA inhibits one or two of these specific
desaturation steps, which are controlled by D6- and D5-
desaturases (Innis, 1993). This was also evident in the syn-
thesis of 22 : 6n-3, which also tended to be sensitive to
changes in CLA concentration. The levels of 22 : 6 were
above basal levels for pigs fed 1·25, 2·50 and 5·0 g CLA/
kg diet, but were lower at the higher doses of CLA. The
content of g-linolenic acid (18 : 3), an intermediate in the
elongation and desaturation step of linoleic acid to arachi-
donic acid, tended to be reduced in the intramuscular fat of
CLA-fed pigs, but the response tended to be quadratic in
nature. Similarly, in mice and rats, CLA was incorporated
into neutral lipids and phospholipids in a dose-response
fashion at the expense of linoleate and arachidonate
(Belury & Kempa-Steczko, 1997). While CLA increased,
arachidonate decreased significantly while linoleate
decreased slightly. The D9,11-18 : 2 isomer of linoleic
acid was found to be a precursor for D5,8,11,13-20 : 4
fatty acid (Belury & Kempa-Steczko 1997). The enzymatic
conversion of linoleate or CLA to 18 : 3 products by D6-
desaturase was similar, suggesting that the enzyme did
not utilize either CLA or linoleate preferentially as a sub-
strate. However, it has not been determined whether CLA
competes with linoleate for D6-desaturase (Belury &
Kempa-Steczko, 1997).
Overall, myristic, palmitic, palmitoleic and oleic acids
were most sensitive to dietary CLA. The relative pro-
portions of saturated fatty acids (16 : 0 and 18 : 0) were sig-
nificantly increased in the intramuscular fat, but not the
adipose tissue and some monounsaturated (18 : 1) and poly-
unsaturated fatty acids (20 : 3, 20 : 4 and 22 : 6) tended to be
reduced by dietary CLA. Overall, saturated fatty acid con-
tent tended to be higher in CLA-fed pigs than control pigs
and the proportion of unsaturated fatty acid tended to
decrease quadratically, with the lowest level detected in
pigs fed 7·50 g/kg and the highest in the control group.
The resulting increase in the ratio saturated : unsaturated
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fatty acids is unfavourable, since increased consumption of
saturated fatty acids it is also associated with increased risk
of CHD. The calculated index of atherogenicity (Ulbricht &
Southgate, 1991), which takes into consideration the CHD
protective and promoting properties of fatty acids, was
also negatively affected by CLA supplementation. There-
fore, applying nutritional techniques to increase the polyun-
saturated and monounsaturated fatty acid content of pork to
compensate for the effects of CLA should be considered.
Conclusion
In conclusion, based on the analytical data from muscle
fat and adipose tissues in the present study, all CLA
isomers were incorporated into pig tissue in a dose-depen-
dant manner. However, there appears to be selectivity in
the uptake or incorporation of the cis,trans-9,11 isomer
over the trans,cis-10,12 isomer. Taking into consideration
the differences the biological activities between the
isomers of CLA, it is important to assess the optimum
levels of the individual isomers in foods and their health
benefit. Furthermore, the increases in CLA concentrations
in carcass lipids due to CLA supplementation were
accompanied by less favourable changes in skeletal
muscle and adipose tissue fatty acid composition.
Therefore, the benefits of CLA-enriched animal products,
possibly in combination with nutritional techniques to
increase the polyunsaturated and monounsaturated fatty
acid content to compensate for the effects of CLA, need
to be evaluated in more detail. Finally, the assessment of
the bioavailability and functional properties of newly
available esterified CLA preparations containing fewer
isomers need to be carried out.
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